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Heterodinuclear ruthenium(II)–cobalt(III) complexes have been prepared as part of investigations into a
new approach to selective cancer treatment. A cobalt(III) centre bearing amine ligands, which serve as
models for cytotoxic nitrogen mustard ligands, is connected by a bridging ligand to a ruthenium(II)–
polypyridyl moiety. Upon excitation of the ruthenium centre by visible light, electron transfer to the
cobalt(III) centre results in reduction to cobalt(II) and consequent release of its ligands. We have
synthesised several such structures and demonstrated their ability to release ligands upon excitation of the
ruthenium centre by visible light.
Introduction
A key concern in the design of anti-cancer treatments is the
selective targeting of cancerous tissue. Many anti-cancer drugs
in use today achieve this discrimination by targeting rapidly pro-
liferating cells.1,2 However, the dosage of such treatments is
limited due to the effect on rapidly dividing normal cells, such
as bone marrow, hair follicles, and epithelial cells lining the
gastrointestinal tract.1 Physiological differences between tumours
and healthy tissue, such as a decrease in pH and oxygen concen-
tration in the former, may offer a superior method of targeting
the tumour environment.3,4
Denny and co-workers have conducted research into hypoxia-
selective treatments consisting of cytotoxic mustard compounds
coordinated to a cobalt(III) centre.5–7 Since coordination to a
metal centre utilises the lone pair of electrons on the nitrogen
atom, and the cytotoxicity of nitrogen mustard compounds relies
on the availability of this lone pair, the toxicity of a nitrogen
mustard compound is much lower in such a complex.5 The
in vivo reduction from a kinetically inert cobalt(III) complex to a
labile cobalt(II) complex would allow for ligand exchange,
releasing the cytotoxic nitrogen mustard into the cell. Tumour
selectivity might be achieved through reoxidation by molecular
oxygen in non-cancerous cells to the inert cobalt(III) oxidation
state (Fig. 1).
We are working on a system in which the reduction of the
cobalt centre and subsequent release of the cytotoxic mustard
compounds may be initiated through the use of light as an exter-
nal stimulus (Fig. 2).8 Connection of the cobalt(III) centre to a
group which can donate an electron upon excitation by an exter-
nal light source should allow selective release of the cytotoxic
molecules at the tumour site using non-invasive techniques.
Light is used as a stimulus in the clinical application of photo-
dynamic therapy, and approaches utilising the photo-induced
release of biologically active molecules from transition metal
based compounds have also been reported.9
Ruthenium polypyridyl complexes have well defined electro-
chemical and photophysical properties that have seen them uti-
lised in many of areas of research,10,11 including solar cells,12
Fig. 1 Reductive activation of cobalt(III) complexes as hypoxia selec-
tive cytotoxins.
Fig. 2 Schematic of a photo-activated cytotoxin: photo-induced elec-
tron transfer from the donor (D) to the acceptor (A) through the bridging
ligand (L) results in release of the cytotoxin (C).
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artificial photosynthesis,13–15 and interactions with DNA and
other nucleic acids.16 The photophysical properties in particular,
and the availability of an extensive synthetic chemistry, make
ruthenium polypyridyl complexes an excellent class of com-
pounds for use as our electron donor.
The design of the bridging ligand is of utmost importance, as
it is this that determines the degree of electronic communication
and rate of electron transfer between the metal centres within a
dinuclear complex.17–23 Furthermore, the choice of bridging
ligand must be made with consideration to a synthetic route that
will allow each metal ion to be placed in the desired binding site
of the ligand. For example, we have previously reported the syn-
thesis of functionalised terpyridine derivatives for use as brid-
ging ligands.24,25 This series was designed with two types of
binding domains, differing in number of donors and/or binding
configuration, with the purpose of preferentially binding ruthe-
nium(II) at one end, and cobalt(III) at the other.
This paper makes use of Sauer’s LEGO system, which pro-
vides a synthetic strategy for the formation of a wide range of
oligopyridines, in particular to produce ligands with multiple
potential metal-binding domains (Fig. 3).26 While the two metal-
binding domains may be very similar in such bridging ligand
systems, selectivity of coordination may be achieved by assem-
bly of the ligand with one domain pre-coordinated to the ruthe-
nium(II) centre. Once added, the second binding domain will be
available for coordination to a cobalt(III) centre. This approach
has been used by the research group of Ji, which has investigated
ruthenium(II) complexes of several such ligands, including
mononuclear complexes bearing a second binding domain.27–31
This approach is ideal for assembly of our proposed photoacti-
vated cytotoxin.
Results and discussion
Synthesis of complexes
The ligands 3-(pyridin-2-yl)-[1,2,4]triazino[5,6-f ][1,10]phenan-
throline (pytp) and 3-(pyrazin-2-yl)-[1,2,4]triazino[5,6-f ][1,10]-
phenanthroline (pztp) were synthesised by condensation of 1,10-
phenanthroline-5,6-dione with pyridine-2-carbohydrazonamide
or pyrazine-2-carbohydrazonamide, respectively, as previously
reported by Sauer.32 These ligands contain two metal-binding
domains, and are therefore capable of binding two different
metal centres.
Crystals of the dihydrochloride salt of pytp that were suitable
for X-ray diffraction studies were obtained by slow evaporation
of a solution of the ligand in dilute hydrochloric acid.
The resulting structural refinement shows the ligand to be
doubly-protonated, with one proton bound to one of the phenan-
throline nitrogen atoms and the other to the pyridyl nitrogen
atom (Fig. 4). The molecules pack in sheets with the two chlor-
ide ions and one solvent water per molecule close to the mean
plane of the ligand. Ligand molecules in different layers are
linked by a chain of hydrogen bonds from the protonated pyridyl
group, to Cl1, through the water molecule to Cl2 and into the
next ligand through the protonated phenanthroline. Although the
ligands are flat and lie parallel to each other with a centroid-to-
plane distance of 3.317 Å, the molecules have poor overlap, thus
π–π interactions appear not to be a stabilising influence.
Attempts to synthesise mononuclear ruthenium(II) complexes
by 1 : 1 reaction of the appropriate bridging ligand with
[Ru(bpy)2Cl2]·2H2O gave poor discrimination between the two
potential binding sites, as seen by Ji et al.31 1H NMR spectra of
the resulting mixtures were consistent with the presence of both
possible mononuclear complexes, along with the diruthenium
complex. Well-defined mononuclear ruthenium(II) complexes
bearing the bridging ligands pytp and pztp, [Ru(bpy)2(pytp)]-
(PF6)2 and [Ru(bpy)2(pztp)](PF6)2, respectively, were synthesised
using the approach of Ji et al. The appropriate carbohydrazona-
mide was reacted with the pre-coordinated phendione complex,
[Ru(bpy)2(phendione)](PF6)2, in order to allow selective for-
mation of complexes in which the Ru(II) ion is bound to the phe-
nanthroline-like binding site of the pytp and pztp ligands (Fig. 5).
Crystals of [Ru(bpy)2(pztp)](PF6)2 suitable for X-ray diffrac-
tion were obtained by the diffusion of diethyl ether into an aceto-
nitrile solution of the complex.
The structure shows that the pztp ligand is bound to the ruthe-
nium centre through the phenanthroline moiety and adopts a
planar conformation, similar to that seen in the pytp ligand struc-
ture described above. This time however the α-nitrogen of the
terminal heterocycle is orientated to form the desired, and more
accessible binding domain for the coordination of a second
metal centre (Fig. 6).
Heterodinuclear complexes
Although homodinuclear ruthenium(II) complexes of pytp28 and
pztp31 are known, there are no reports of any heterodinuclear
ruthenium(II) complexes of these ligands. Evidence for the
ability of the second binding domain to coordinate to a different
metal was gathered by monitoring the interaction of the mono-
nuclear ruthenium(II) complexes with silver(I) using 1H NMR
spectroscopy.
Fig. 4 X-ray crystal structure of pytp·2HCl.
Fig. 3 3-(pyridin-2-yl)-[1,2,4]triazino[5,6-f][1,10] phenanthroline (pytp)
and its potential metal ion binding domains.
14426 | Dalton Trans., 2012, 41, 14425–14432 This journal is © The Royal Society of Chemistry 2012
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[Ru(bpy)2(pytp)](PF6)2 was dissolved in acetonitrile-d3 and
AgClO4 added slowly. This resulted in a gradual shift of several
of the resonances associated with the pytp ligand, until the ratio
of added silver(I) to ruthenium(II) complex was 1 : 1 (Fig. 7).
Further addition of silver had minimal affect on the position of
the pytp resonances. This is consistent with one to one binding
of silver ions, and a fast equilibrium between the bound and
unbound state. If the silver was irreversibly bound or the rate of
exchange slow on the NMR timescale, then it would be expected
that a new set of peaks would appear with the addition of
AgClO4. Experiments with salts of zinc(II) or copper(I) ions give
similar results, while experiments using non-transition metal
salts, NaClO4 and LiCl revealed no evidence for interaction
between the ligand and the added metal ions.
Following a silver(I) NMR titration, a portion of the solution
was analysed by mass spectrometry. The spectrum showed three
major isotope patterns that were of interest. These were at m/z
ratios of approximately 362, 466, and 823 and correspond to
[Ru(bpy)2(pytp)]
2+, [(bpy)2Ru(pytp)Ag](ClO4)
2+ and [Ru(bpy)2-
(pytp)](ClO4)
+ respectively. This provides further evidence for
the binding of silver(I) to the second binding domain of the pytp
ligand. Similar results were obtained with [Ru(bpy)2(pztp)]-
(PF6)2.
Given that the free binding domains of the mononuclear
complexes [Ru(bpy)2(pytp)](PF6)2 and [Ru(bpy)2(pztp)](PF6)2
are able to coordinate to silver(I) ions, we inferred that they
should be suitable for coordination to a cobalt(III) centre. In
order to explore this possibility and study the chemistry of the
resulting systems, cobalt(III) complexes of the ligands ethane-
1,2-diamine (en) and tris(2-aminoethyl)amine (tren) were used.
The binding domain of en is similar to that of the bidentate
nitrogen mustards that we eventually hope to study, N,N′-bis(2-
chloroethyl)ethane-1,2-diamine and N,N-bis(2-chloroethyl)ethane-
1,2-diamine, while tren, being tetradentate, should be more
stable towards substitution.
The Ohno group has prepared heterodinuclear ruthenium(II)–
cobalt(III) complexes utilising bidentate and tridentate poly-
pyridyl bridging ligands. This was achieved by heating of a
ruthenium(II) complex of the bridging ligand with a cobalt(III)
complex bearing exchangeable ligands such as Cl− or
CF3SO3
−.33,34 Attempts to form a heterodinuclear complex by
heating [Ru(bpy)2(pytp)](PF6)2 with [Co(en)2Cl2]Cl, in aqueous
solvents, resulted in products that were unable to be characterised
by NMR spectroscopy due to broadening of signals, possibly
due to formation of paramagnetic compounds. However, the use
of triflate complexes allowed for the synthesis of ruthenium(II)–
cobalt(III) heterodinuclear complexes under milder, non-aqueous
conditions (Fig. 8).
An acetonitrile solution containing the ruthenium(II) precursor
complex, [Ru(bpy)2(pytp)]
2+ or [Ru(bpy)2(pztp)]
2+, and either
Fig. 6 X-ray crystal structure of Ru[(bpy)2(pztp)](PF6)2·1.5(CH3CN);
counter ions and solvent molecules have been omitted for clarity.
Fig. 5 Synthesis of the ligands pytp (X = CH) and pztp (X = N) on a
ruthenium(II) metal centre (counter-ions omitted for clarity). The atomic
labels refer to the NMR assignment for [Ru(bpy)2(pytp)](PF6)2.
Fig. 7 Aromatic region of 1H NMR spectra of [(bpy)2Ru(pytp)](PF6)2
in CD3CN with: (a) 0 equivalents of Ag(ClO4); (b) 0.3 equivalents of
Ag(ClO4); (c) 1 equivalent of Ag(ClO4).
This journal is © The Royal Society of Chemistry 2012 Dalton Trans., 2012, 41, 14425–14432 | 14427
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[Co(en)2(OTf)2]OTf or [Co(tren)(OTf)2]OTf was stirred at room
temperature in a flask protected from light, in order to eliminate
the possibility of photoinduced decomposition. The heterodinuc-
lear complexes were then isolated as the PF6
− salts. While het-
erodinuclear complexes utilising both pytp and pztp as bridging
ligands were synthesised, those containing pztp proved to be
unstable in solution, and so discussion from this point focuses
on complexes of pytp.
Additional syntheses were conducted on the NMR scale, so
that the formation of the product could be monitored by 1H
NMR spectroscopy. The series of spectra shows a decrease in
the size of the peaks which are assigned to the starting material,
and a corresponding increase in the size of the peaks assigned to
the product (Fig. 9).
The UV-vis spectra of both heterodinuclear ruthenium(II)–
cobalt(III) complexes are rather similar to those of the mono-
nuclear ruthenium(II) complexes, except that λmax is red-shifted
by 6–7 nm, and there is an increase in absorbance in the region
below 400 nm.
Electrochemistry
The electrochemistry of [Ru(bpy)2(pytp)](PF6)2 and [(bpy)2Ru-
(pytp)Co(tren)](PF6)5 was studied in acetonitrile with TBABF4
as an electrolyte and ferrocene as an internal standard (Table 1).
Both complexes undergo a reversible oxidation process and
several reversible or quasi-reversible reduction processes. In both
cases, the reversible oxidation is ascribed to the Ru(II)/Ru(III)
couple. In the case of the mononuclear complex [Ru-
(bpy)2(pytp)](PF6)2, all the reduction waves can be ascribed to
ligand based reductions, with the first wave at −1.22 V assigned
to the reduction of the pytp ligand. For the dinuclear complex,
the first quasi-reversible reduction wave at −0.26 V can be attri-
buted to the reduction of the cobalt(III) centre to cobalt(II), with
the absence of reversibility rationalised as being due to the rela-
tively rapid exchange of the ligands on the metal centre in the
cobalt(II) state. In further evidence for this interpretation, larger
oxidation currents are observed when scanning to less negative
potentials. The second wave, at −0.84 V, is assigned to the
reduction of the pytp bridging ligand. Its appearance at a more
positive potential, compared with −1.22 V in the mononuclear
complex, is attributable to the higher positive charge on the
dinuclear complex, making the reduction easier. In both cases,
the most negative reduction wave is likely to be due to bipyridine
ligand-based reductions.
Luminescence studies
Both the mononuclear complex, [Ru(bpy)2(pytp)](PF6)2, and the
heterodinuclear complex [(bpy)2Ru(pytp)Co(tren)](PF6)5 were
shown to luminesce at room temperature, as might be expected
for ruthenium(II) polypyridyl complexes.35 The steady state
emission intensity of dinuclear complex was observed to be sig-
nificantly less than that measured for the mononuclear complex
(Fig. 10).
The emission lifetimes of both complexes were calculated by
fitting an exponential curve to the observed time-resolved emis-
sion data. The mononuclear complex was found to have a life-
time of 212 ns, while the heterodinuclear complex was found to
have a lifetime of 72 ns. The quantum yields were calculated,
using [Ru(bpy)3]Cl2 as a standard, with a known quantum yield
of 4.2%.36 From these measurements the mononuclear complex
was found to have a quantum yield of 1.11% and the hetero-
dinuclear complex a significantly lower quantum yield of 0.21%,
Fig. 8 Synthetic route to [Ru(bpy)2(pytp)Co(tren)](PF6)5 in aceto-
nitrile. Counter ions omitted for clarity. The atomic labels refer to the
NMR assignment for [(bpy)2Ru(pytp)Co(tren)](PF6)5.
Fig. 9 Aromatic regions of the 1H NMR spectra taken during the reac-
tion between [Ru(bpy)2(pytp)]
2+ and [Co(tren)(OTf)2]
+ in CD3CN; the
top spectrum is primarily [Ru(bpy)2(pytp)]
2+ (labelled peaks) while the
bottom spectrum is primarily the heterodinuclear complex [(bpy)2-
Ru(pytp)Co(tren)]5+ (labelled peaks).
Table 1 Redox potentials (V, referenced to Fc+/Fc0) of [Ru(bpy)2-
(pytp)](PF6)2 (Ru) and [(bpy)2Ru(pytp)Co(tren)](PF6)5 (Ru/Co)
Ru3+/2+ Co3+/2+ pytp/pytp˙− bpy/bpy˙−
Ru 0.96 — −1.22 −1.77
Ru/Co 1.00 −0.26 −0.84 −1.64
14428 | Dalton Trans., 2012, 41, 14425–14432 This journal is © The Royal Society of Chemistry 2012
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consistent with the differences in steady state emission
intensities.
All of these measurement are consistent with coordination of
the cobalt(III) metal centre, resulting in a quenching of the
excited-state luminescence. Furthermore, if we assume that the
ruthenium–polypyridyl-centred radiative and non-radiative decay
paths are the same for both complexes, then the rate of electron
transfer to the cobalt can be approximated. Using the formula
kobs = krad + knonrad + ket and assuming that (krad + knonrad) is
equal to kobs of the mononuclear complex, for the hetero-
dinuclear complex, we obtain a value of 9.6 × 106 s−1 for ket.
Photoactivated ligand release
A sample of [(bpy)2Ru(pytp)Co(en)2](PF6)5 was dissolved in
1 : 1 D2O : acetonitrile-d3 in a 5 mm NMR tube and irradiated
under white light at room temperature. The sample was removed
from irradiation at regular intervals in order for 1H NMR spectra
to be recorded. This revealed the appearance and growth over
time of a new singlet peak at 3.21 ppm (Fig. 11), which has
been assigned to the two methylene groups on the noncoordi-
nated en ligand.
Under the same conditions, [(bpy)2Ru(pytp)Co(tren)](PF6)5
showed similar behaviour. Two triplets appeared at 2.99 and
2.73 ppm, corresponding to noncoordinated tren in solution
(Fig. 12).
The dependence of ligand release on oxygen concentration
was examined by repetition of the above experiment utilising
[(bpy)2Ru(pytp)Co(en)2](PF6)5 under different levels of solution
oxygen concentration. The first sample had no treatment to
control its oxygen concentration, the second was bubbled with
nitrogen for one minute, and the third was run through a succes-
sion of freeze–pump–thaw cycles with nitrogen back-fill to
prevent excessive solvent evaporation. The three samples were
then irradiated as described above and the amount of en released
was estimated by comparison of the integral of the singlet at
3.21 ppm, assigned to noncoordinated en, with the integral of
the peak at 9.21 ppm, corresponding to the pytp bridge in the
heterodinuclear complex. Plotting the percentage of ligand
released as a function of time (Fig. 13) revealed that the ligand
was released the fastest in the sample that had been cycled
through the freeze–pump–thaw process. The second fastest
release of ligand was seen in the nitrogen degassed sample,
Fig. 10 Comparison of the emission spectra of [Ru(bpy)2 (pytp)]
2+
(upper line) and [(bpy)2Ru(pytp)Co(tren)]
5+ (lower line) in CH3CN.
Fig. 11 Photo-induced release of en from [(bpy)2Ru(pytp)Co(en)2]
5+,
as seen in aliphatic region of 1H NMR spectra; the peak associated with
the free en molecule is marked (*). Spectra shown were taken after
(from top to bottom) 0, 10, 30, 60, 120 and 180 minutes irradiation.
Fig. 12 Photo-induced release of tren from [(bpy)2Ru(pytp)Co-
(tren)]5+, as seen in aliphatic region of 1H NMR spectra the peaks
associated with the free tren molecule are marked (*). Spectra shown
were taken after (from top to bottom) 0, 60, 120, 180 and 240 minutes
irradiation.
Fig. 13 Difference in rate of ligand release between samples that have
undergone freeze–pump–thaw cycles (◆), N2 bubbling (▲) and no treat-
ment to remove oxygen (■).
This journal is © The Royal Society of Chemistry 2012 Dalton Trans., 2012, 41, 14425–14432 | 14429
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which shows that the rate of ligand release is dependent on the
concentration of oxygen in solution. This oxygen dependence
may be due to reoxidation of the Co(II) centre by dissolved
oxygen competing with the exchange of the coordinated ligands
for solvent molecules. Other possibilities do exist, however, such
as interaction/deactivation of the ruthenium-centred excited state
with oxygen. This kind of oxygen-dependent ligand release may
enable selective targeting of hypoxic cells, such as those found
in poorly vascularised tumours.
Conclusions
Ruthenium(II)–cobalt(III) heterodinuclear complexes utilising
pytp and pztp as bridging ligands have been synthesised and
characterised. Coordination of the second binding domain to
cobalt was found to decrease the luminescence, and shorten the
excited state lifetime of the complexes. This is attributed to elec-
tron transfer to the cobalt(III) centre providing additional relax-
ation pathways for the excited state. Furthermore, coordination to
cobalt(III) was found to raise the reduction potential of the brid-
ging ligand pytp. Photoactivated release of the ancillary ligands
on cobalt(III) has been demonstrated. These results suggest com-
pounds of this kind may be able to be used as a light activated
selective cancer treatment, and justify further research utilising
nitrogen mustard molecules as the ancillary ligands on the cobalt
centre.
Experimental
General experimental
1H and 13C NMR spectra were recorded on Varian UNITY-300
or Varian INOVA-500 spectrometers. Chemical shifts are
expressed in parts per million (ppm) on the δ scale and were
referenced to residual solvent resonances or to TMS as an
internal reference. NMR spectra were assigned using two-dimen-
sional techniques.
High Resolution Electrospray Ionisation Mass Spectra were
recorded on a Micromass LCT spectrometer using a probe
voltage of 3200 V, an operating temperature of 150 °C and a
source temperature of 80 °C.
UV-visible spectra were recorded on a Varian CARY Probe 50
UV-vis spectrophotometer or a Varian CARY 100 UV-vis
spectrophotomer.
X-Ray crystal data was collected on a Bruker-Nonius APEX II
system using graphite monochromatised Mo Kα (l = 0.71073 Å)
radiation at the temperature indicated in the tables that may be
found in the ESI.† The data collection, cell determination and
data reduction were all performed with the APEX software. All
structures had intensities corrected for Lorentz and polarisation
effects and for absorption using SAINT. All structures were
solved by direct methods using SHELXS and refined on F2
using all data by full-matrix least squares procedures using
SHELXL-97. All non-hydrogen atoms were refined anisotropi-
cally, and hydrogen atoms were (C–H) placed in idealised posi-
tions with displacement parameters 1.2 and 1.5 times the
isotropic equivalent of their carrier carbon atoms or (X–H)
located in the electron density map and allowed to refine at a
fixed distance (O–H d = 0.82 Å, N–H d = 0.86 Å) with
displacement parameters 1.5 times the isotropic equivalent of
their carrier atoms.
Steady state absorption measurements were performed using
an absorption spectrometer (Cary Bio50, Varian). Steady state
emission spectra were acquired with an emission spectrometer
(Cary Eclipse, Varian). Quantum yield measurements were per-
formed using the optically dilute method, using [Ru(bpy)3]Cl2 in
aqueous solution as a standard (Φref = 4.2%).
36 Time resolved
emission lifetime experiments were performed using a nano-
second laser setup. The 355 nm tripled output of a Q-switched
Nd:YAG (Continuum NY-61-10, Coherent) was used to drive an
OPO system (Casix BBO, Shanghai Uniwave Technologies)
which was tuned to 440 nm, and this output was focused on the
sample using all quartz optics. Emission was collected perpen-
dicular to the excitation, collimated then refocused onto the
entrance port of a 0.3 m triple grating monochromator (Spectra-
Pro 300i, Acton Instruments) for spectral selection at 630 nm.
The detector was a PMT tube (R928P, Hamamatsu), the output
of which was sampled directly using a 500 MHz digital oscillo-
scope (TDS520, Tektronix). The instrument response function
(IRF) for this setup was measured using scattered excitation to
be ca. 8 ns at FWHM. Each resulting trace contained at least
1000 data points, and was averaged over 1000 shots. Data analy-
sis was performed using a commercially available software
package (Igor, Version 6.1.2.1, Wavemetrics). The quality of the
fit was assessed using the reduced chi-squared χ2 function and
by an inspection of the weighted residuals.
All electrochemical measurements were carried out in nitro-
gen-purged acetonitrile using a computer-controlled Ecochemie
Autolab PGSTAT 302 potentiostat. The working electrode was a
Pt electrode, the secondary electrode was an Au wire and the
pseudo-reference electrode was a silver wire. The reference was
set to an internal ferrocene/ferrocinium sample. The concen-
tration of the compounds was about 1 mM. Tetrabutylammonium
tetrafluoroborate (TBABF4) was used as supporting electrolyte at
a concentration of 0.1 M. Cyclic voltammograms were obtained
at scan rates of 100 mV s−1. Half-wave potentials were measured
with squarewave voltammetry experiments performed with a
step potential of 5 mV, an amplitude of 20 mV, and a frequency
of 8 Hz.
Preparations
Pyridine-2-carbohydrazonamide,37 pyrazine-2-carbohydrazona-
mide,37 3-(pyridin-2-yl)-[1,2,4]triazino[5,6-f][1,10]phenanthroline
(pytp),32 3-(pyrazin-2-yl)-[1,2,4]triazino[5,6-f][1,10]phenanthroline
(pztp),32 [Ru(bpy)2(phendione)](PF6)2,
38 [Co(tren)(OTf)2]OTf
39
and [Co(en)2(OTf)2]OTf
39 were prepared according to published
procedures.
Single crystals of C18H14Cl2N6O were prepared by slow evap-
oration of an aqueous HCl solution. A suitable crystal was
mounted in a perfluoronated oil and placed in the cold stream of
a diffractometer.
Crystal structure determination of pytp·2HCl
Crystal data. C18H14Cl2N6O, M = 401.25, triclinic, a =
8.3203(2) Å, b = 9.8047(3) Å, c = 11.3191(4) Å, α = 112.3820(10)°,
14430 | Dalton Trans., 2012, 41, 14425–14432 This journal is © The Royal Society of Chemistry 2012
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β = 93.764(2)°, γ = 93.041(2)°, V = 848.93(4) Å3, T = 118(2),
space group P1ˉ (no. 2), Z = 2, μ(MoKα) = 0.406, 22 950 reflec-
tions measured, 4919 unique (Rint = 0.0863) which were used in
all calculations. The final wR2 was 0.1054 (all data) and R1 was
0.0366 (I > 2σ(I)).
[Ru(bpy)2(pytp)](PF6)2. [Ru(bpy)2(pytp)](PF6)2 was synthe-
sised by a modification of the literature method of Zou.31 A sol-
ution of pyridine-2-carbohydrazonamide (0.076 g) in ethanol
(5 mL) was added to a solution of [Ru(bpy)2(phendione)](PF6)2·
H2O (0.5 g) in acetonitrile (15 mL). The reaction mixture was
heated at reflux for one hour, after which it was filtered through
celite and the solvent removed under vacuum. The crude product
was dissolved in acetonitrile and purified by column chromato-
graphy (silica gel, acetonitrile/saturated aqueous KNO3 7 : 1).
The major red band was collected and the product converted to
the PF6
− salt. The solvent was removed under vacuum and the
resulting solid dissolved in acetonitrile. The solution was added
to vigorously stirred water to precipitate the product which was
filtered and washed with 0 °C water, 0 °C ethanol and ether.
Yield 0.30 g (52%). Characterisation data were consistent with
those previously reported.30
[Ru(bpy)2(pztp)](PF6)2. A solution of pyrazine-2-carbohydra-
zonamide (0.08 g) in ethanol (5 mL) was added to a solution of
[Ru(bpy)2(phendione)](PF6)2·H2O (0.5 g) in acetonitrile
(15 mL). The reaction mixture was heated at reflux for one hour,
after which it was filtered through celite and the solvent removed
under vacuum. The crude product was dissolved in acetonitrile
and purified by column chromatography (silica gel, acetonitrile/
saturated aqueous KNO3 7 : 1). The major red band was col-
lected and the product converted to the PF6
− salt. The solvent
was removed under vacuum and the resulting solid dissolved in
acetonitrile. The solution was added to vigorously stirred water
to precipitate the product which was filtered and washed with
0 °C water, 0 °C ethanol and ether.
Yield 0.24 g (42%). 1H NMR (500 MHz; CD3CN) δ 10.07
(m, 1 H), 9.82 (m, 1 H), 9.72 (m, 1 H), 8.96 (m, 1 H), 8.90 (m,
1 H), 8.54 (m, 4 H), 8.31 (m, 1 H), 8.28 (m, 1 H), 8.13 (m, 2 H),
8.03 (m, 2 H), 7.96 (m, 2 H), 7.85 (m, 2 H), 7.70 (m, 2 H), 7.48
(m, 2 H), 7.27 (m, 2 H). Anal. Calc. for C37H25F12N11P2Ru·
2H2O (1050.70): C 42.30, H 2.78, N 14.66%; Found: C 42.57,
H 2.96, N 14.56. UV-vis (CH3CN): λmax/nm 439.
Single crystals of C40H29.5F12N12.5P2Ru were prepared by dif-
fusion of diethyl ether into an acetonitrile. A suitable crystal was
mounted in a perfluoronated oil and placed in the cold stream of
a diffractometer.
Crystal structure determination of Ru[(bpy)2(pztp)](PF6)2·
1.5(CH3CN)
Crystal data. C80H59F24N25P4Ru2, M = 2152.54, triclinic, a =
11.8919(7) Å, b = 12.3372(7) Å, c = 15.9036(10) Å, α =
81.000(4)°, β = 77.789(4)°, γ = 66.668(4)°, V = 2087.1(2) Å3,
T = 118(2), space group P1ˉ (no. 2), Z = 1, μ(MoKα) = 0.556,
34 975 reflections measured, 7380 unique (Rint = 0.1090) which
were used in all calculations. The final wR2 was 0.1393 (all data)
and R1 was 0.0559 (I > 2σ(I)).
[(bpy)2Ru(pytp)Co(tren)](PF6)5. The complexes [Ru(bpy)2-
(pytp)](PF6)2 (0.0586 g) and [Co(tren)(OTf)2]OTf (0.0377 g)
were placed in an aluminium foil-wrapped 25 mL round bottom
flask. Acetonitrile (2 mL) was added, the flask stoppered and the
solution stirred for 3 hours at room temperature. The product
was precipitated out as the PF6
− salt by drop wise addition to a
stirred solution of 3 mL saturated methanolic NH4PF6 diluted in
60 mL water.
Yield 0.0515 g (54%). 1H NMR (500 MHz; CD3CN) δ 9.86
(dd, 1 H, pytp, c), 9.59 (dd, 1 H, pytp, h), 9.33 (dd, 1 H, pytp,
d), 8.88 (d, 1 H, pytp, g), 8.69 (t, 1 H, pytp, e), 8.56 (m, 4 H,
bpy), 8.49 (dd, 1 H, pytp, a), 8.41 (dd, 1 H, pytp, j), 8.23 (m,
1 H, pytp, f ), 8.14 (m, 2 H, bpy), 8.09–8.03 (m, 4 H, pytp (b, i),
bpy), 7.85 (m, 2 H, bpy), 7.75 (dd, 1 H, bpy), 7.69 (dd, 1 H,
bpy), 7.49 (m, 2 H, bpy), 7.29 (m, 2 H, bpy), 5.30 (br s, 2 H,
tren, NH2), 4.64 (m, 2 H, tren), 4.36 (br s, 2 H, tren, NH2), 4.12
(m, 2 H, tren, NH2), 3.64 (m, 4 H, tren), 3.17 (m, 6 H, tren).
13C NMR (75 MHZ; CD3CN) δ 165.17, 159.78 (pytp, a),
158.01 (bpy), 157.82 (pytp, j), 157.79, 155.53 (pytp, g),
154.60, 153.10 (bpy), 152.99 (bpy), 152.47, 151.85, 148.53,
147.13, 144.77 (pytp, e), 139.28 (bpy), 139.26 (bpy), 139.22
(bpy), 139.19 (bpy), 136.41 (pytp, c), 135.05 (pytp, h), 132.96
(pytp, f ), 130.38 (pytp, d), 128.68 (bpy), 128.63 (bpy), 128.58
(bpy), 127.81, 127.77, 125.40 (bpy), 65.25 (tren), 61.88 (tren),
47.87 (tren), 44.97 (tren). Anal. Calc. for C44H44CoF30N14-
P5Ru·3CH3OH·2H2O (1785.93): C 31.61, H 3.39, N 10.98%;
found: C 31.70, H 3.50, N 11.05%. ESI-MS: m/z (fragment)
1508.6479 ([M − (PF6)]+), 362.2408 ([M − 3(PF6)]3+). UV-vis
(CH3CN): λmax/nm 206, 253, 285, 444.
[(bpy)2Ru(pytp)Co(en)2](PF6)5. The complexes [Ru(bpy)2-
(pytp)](PF6)2 (0.0410 g) and [Co(en)2(OTf)2]OTf (0.0263) were
placed in an aluminium foil-wrapped 25 mL round bottom flask.
Acetonitrile (2 mL) was added, the flask stoppered and the solu-
tion stirred for 3 hours at room temperature. The product was
precipitated out as the PF6
− salt by drop wise addition to a
stirred solution of 3 mL saturated methanolic NH4PF6 diluted in
60 mL water.
Yield 0.0420 g (64%). 1H NMR (500 MHz; CD3CN) δ 9.85
(m, 1 H), 9.78 (m, 1 H), 9.30 (d, 1 H), 8.83 (d, 1 H), 8.71 (t,
1 H), 8.55 (m, 4 H), 8.47 (m, 1 H), 8.41 (m, 1 H), 8.27 (m, 1 H),
8.14 (m, 2 H), 8.06 (m, 4 H), 7.84 (m, 2 H), 7.74 (t, 1 H), 7.69
(t, 1 H), 7.49 (m, 2 H), 7.30 (m, 2 H), 3.16 (m, 4 H), 3.76 (m,
4 H). Anal. Calc. for C42H42F30N14P5CoRu·CH3OH·3H2O
(1713.82): C 30.14, H 3.06, N 11.44%; Found: C 30.32, H 3.26,
N 11.59%. UV-vis (CH3CN): λmax/nm 445.
[(bpy)2Ru(pztp)Co(en)2](PF6)5. The complexes [Ru(bpy)2-
(pztp)](PF6)2 (0.0364 g) and [Co(en)2(OTf)2]OTf (0.0246 g)
were placed in an aluminium foil-wrapped 25 mL round bottom
flask. Acetonitrile (2 mL) was added, the flask stoppered and the
solution stirred for 3 hours at room temperature. The product
was precipitated out as the PF6
− salt by drop wise addition to a
stirred solution of 3 mL saturated methanolic NH4PF6 diluted in
60 mL water.
Yield 0.0199 g. 1H NMR (500 MHz; CD3CN) δ 9.63 (s, 1 H),
9.17 (d, 1 H), 9.13 (m, 1 H), 8.71 (d, 1 H), 8.31 (t, 1 H), 7.85
(m, 4 H), 7.79 (dd, 1 H), 7.73 (m, 1 H), 7.68 (dd, 1 H), 7.44
(m, 2 H), 7.38–7.31 (m, 4 H), 7.14 (m, 2 H), 6.92 (m, 1 H), 6.78
This journal is © The Royal Society of Chemistry 2012 Dalton Trans., 2012, 41, 14425–14432 | 14431
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(m, 2 H), 6.60 (m, 1 H), 6.51 (m, 1 H). UV-vis (CH3CN):
λmax/nm 445.
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